Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases 2.0
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (26 September 2023) | Viewed by 177
Special Issue Editors
Interests: monoclonal antibodies; vaccines; hepatitis C virus; influenza virus; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Interests: activation of humoral immune response to influenza infection or vaccination; antibody functionality and crosstalk with innate immune system; impact of pre-immunity during influenza infection or vaccination
Special Issues, Collections and Topics in MDPI journals
Interests: monoclonal antibodies; vaccines; hepatitis C virus; influenza virus; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immune-based tools have been extensively used in order to develop diagnostic, vaccinal, and therapeutic countermeasures to combat infectious diseases. As an example, the engineering of the immune system has always been exploited to improve the specificity and functional characteristics of immune cells and molecules, such as in the case of chimeric antigen receptors. Novel anti-infective monoclonal antibodies are also approaching the clinics in the next few years, and many more are currently under development. In particular, thanks to their high specificity, antibodies can also be very useful in the early diagnosis of infectious diseases. The availability of such specific reagents is thus pivotal to study host–pathogen interaction as well as to develop innovative approaches to eradicate infections. Recent high-throughput technologies are allowing to unravel the antibody repertoire in depth, such as in the context of certain infections or following immunization, for which it is important to understand what the key determinants conferring the protection are. After the success of the previous Special Issue on “Immunodiagnostic, Immunoprophylactic, and Immunotherapeutic Approaches against Infectious Diseases”, we are pleased to invite researchers to contribute to the second Special Issue. In this Special issue, we encourage the submission of papers on recent advances in the field, especially focusing on how we can exploit the immune system to understand new host–pathogen relationships as well as for the development of novel prophylactic, therapeutic, and diagnostic tools.
Dr. Giuseppe A. Sautto
Dr. Rodrigo Bessa Abreu
Dr. Roberta Antonia Diotti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- monoclonal antibodies
- vaccines
- immunotherapy
- immunodiagnosis
- immunoprophylaxis
